Postoperative serum triglyceride levels in predicting risk of new-onset diabetes mellitus in patients following liver transplantation

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2021 Apr 25;50(2):239-244. doi: 10.3724/zdxbyxb-2021-0114.

Abstract

To investigate the postoperative serum triglyceride (TG) levels in predicting the risk of new-onset diabetes mellitus (NODM) in patients following allogeneic liver transplantation. One hundred and forty three patients undergoing allogeneic liver transplantation in Shanghai General Hospital from July 2007 to July 2014 were enrolled in this study. The NODM developed in 33 patients after liver transplantation. The curve of dynamic TG levels in the early period after liver transplantation was generated. Independent risk factors of NODM were determined by univariate and multivariant logistic regression analyses. The clinical value of TG in predicting NODM was analyzed by area under the ROC curve (AUC). Serum TG levels were gradually rising in the first week and then reached the plateau phase (stable TG, sTG) in patients after surgery. The sTG in NODM group were significantly higher than that in non-NODM group (=-2.31, <0.05). Glucocorticoid therapy (=4.054, <0.01), FK506 drug concentration in the first week after operation (=3.482, <0.05) and sTG (=3.156, <0.05) were independent risk factors of NODM. ROC curve analysis showed that the AUC of sTG in predicting NODM was 0.72. TG shows a gradual recovery process in the early period after liver transplantation, and the higher TG level in stable phase may significantly increase the risk of NODM in patients.

Keywords: Dyslipidemia; Hypertriglyceridemia; New-onset diabetes mellitus after liver transplantation; Prediction; Regression analysis.

MeSH terms

  • China / epidemiology
  • Diabetes Mellitus* / epidemiology
  • Diabetes Mellitus* / etiology
  • Humans
  • Liver Transplantation* / adverse effects
  • Risk Factors
  • Tacrolimus / adverse effects
  • Triglycerides

Substances

  • Triglycerides
  • Tacrolimus

Grants and funding

上海交通大学“医工交叉基金”(YG2019QNB36); 上海申康医院发展中心临床科技创新项目(SHDC12018X15); 上海市第一人民医院临床研究创新团队项目(CTCCR-2018BP01)